Nasdaq Ocea News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ocea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ocea Today - Breaking & Trending Today

Ocean Biomedical, Inc. Announces Receipt of Notice from

PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a. ....

United States , Rhode Island , Kevin Kertscher , Ocean Biomedical Inc , Communications Director , Company Annual Report On Form , Exchange Commission , Nasdaq Stock Market , Annual Report , Nasdaq Listing Rule , Ocean Biomedical , Rhode Island Based , Annual Reports , Nasdaq Ocea , Ocean Biomedical , Nasdaq Ocea , Nasdaq Regarding Late Filing , Nnual Report On Form 10 K , Biopharma Company ,

Ocean Biomedical, Inc. Announces Receipt of Notice from

PROVIDENCE, Rhode Island, Nov. 29, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 22, 2023, it received. ....

United States , Rhode Island , Kevin Kertscher , Exchange Commission , Nasdaq Stock Market , Communications Director , Vellar Opportunity Fund , Meteora Special Opportunity Fund , Strategy Master Fund , Company Annual Report On Form , Ocean Biomedical Inc , Nasdaq Listing Rule , Ocean Biomedical , Forward Purchase Agreements , Meteora Select Trading Opportunities Master , Polar Multi Strategy Master , Rhode Island Based , Annual Report , Quarterly Reports , Nasdaq Ocea , Ocean Biomedical , Biopharma Company , Reatment Of Malaria , Pulmonary Fibrosis , Brain Cancer , Lung Cancer ,

Updated: Ocean Biomedical Announces Non-Dilutive Amendment

Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA) announces that the company and Polar Multi-Strategy Master Fund. ....

United States , Kevin Kertscher , Chirinjeev Kathuria , Ocean Biomedical Inc , Communications Director , Strategy Master Fund Polar , Company Annual Report On Form , Polar Multi Strategy Master Fund , Side Letter , Forward Purchase Agreement , Reset Price , Executive Chairman , Rhode Island Based , Ocean Biomedical , Annual Report , Quarterly Reports , Nasdaq Ocea , Ocean Biomedical , Nasdaq Ocea , Polar Multi Strategy Master , On Dilutive Amendment , Eller Vwap Trigger Event ,

Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now

Ocean Biomedical will host a Research and Development Day, Live Q&A with Scientific Co-founders, Dr. Jack A. Elias, MD and Dr. Jonathan Kurtis, MD, PhD. ....

United States , Kevin Kertscher , Chirinjeev Kathuria , Jonathan Kurtis , Gurinder Kalra , Jacka Elias , Research Corporation , White Lion Capital , Alto Opportunity Master Fund , Ocean Biomedical Inc , Development Day , Communications Director , Company Annual Report On Form , Company Comment , Ocean Biomedical , Scientific Co Founders , Fundamental Research Corporation , Executive Chairman , Rhode Island Based , Annual Report , Quarterly Reports , Nasdaq Ocea , Ocean Biomedical , Nasdaq Ocea , Next Generation , Biopharma Company ,

Ocean Biomedical, Inc. Enters into a $25 Million

Providence, RI, May 16, 2023 (GLOBE NEWSWIRE) Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and. ....

United States , Chirinjeev Kathuria , Waqas Khatri , Suren Ajjarapu , Dykema Gossett , Company Annual Report On Form , Kelley Drye Warren , Exchange Commission , Alto Opportunity Master Fund , Maxim Group , Ocean Biomedical Inc , Senior Secured Convertible Promissory Notes , Ocean Biomedical , Kelley Drye , Securities Purchase Agreement , Current Report , Rhode Island Based , Annual Report , Biomedical Media , Nasdaq Ocea , Ocean Biomedical , Nasdaq Ocea , Biopharma Company , Innovative Business Model , R Chirinjeev Kathuria , Maxim Group Llc ,